Evaluation of ifosfamide for treatment of various canine neoplasms.

Journal of veterinary internal medicine / American College of Veterinary Internal Medicine

Volumn 14, Issue 3, 2000, Pages 271-276

  Rassnick, K M ^a   Frimberger, A E ^a   Wood, C A ^a   Williams, L E ^a   Cotter, S M ^a   Moore, A S ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; IFOSFAMIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; FEMALE; INFORMATION PROCESSING; LYMPHOMA; MALE; MORTALITY; RETROSPECTIVE STUDY; SARCOMA; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; DOG DISEASES; DOGS; FEMALE; IFOSFAMIDE; LYMPHOMA; MALE; MASSACHUSETTS; RECORDS; RETROSPECTIVE STUDIES; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034183434     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2000.tb01166.x     Document Type: Article

References (0)